FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103156714> ?p ?o ?g. }

• W2103156714 endingPage "5572" @default.
• W2103156714 startingPage "5564" @default.
• W2103156714 abstract "Abstract Purpose: REOLYSIN (Oncolytics Biotech) consists of a wild-type oncolytic reovirus, which has selective cytotoxicity for tumor cells while sparing normal cells. In a phase I study as a single agent, repeated infusions of reovirus were safe with evidence of antitumor activity. Preclinical studies indicate potential for synergy between reovirus and chemotherapeutic agents. A multicenter, phase I dose escalation study was designed to assess the safety of combining reovirus with docetaxel chemotherapy in patients with advanced cancer. Experimental Design: Patients received 75 mg/m2 docetaxel (day 1) and escalating doses of reovirus up to 3 × 1010 TCID50 (days 1-5) every 3 weeks. Results: Twenty-five patients were enrolled, and 24 patients were exposed to treatment, with 23 completing at least one cycle and 16 suitable for response assessment. Dose-limiting toxicity of grade 4 neutropenia was seen in one patient, but the maximum tolerated dose was not reached. Antitumor activity was seen with one complete response and three partial responses. A disease control rate (combined complete response, partial response, and stable disease) of 88% was observed. Immunohistochemical analysis of reovirus protein expression was observed in posttreatment tumor biopsies from three patients. Conclusion: The combination of reovirus and docetaxel is safe, with evidence of objective disease response, and warrants further evaluation in a phase II study at a recommended schedule of docetaxel (75 mg/m2, three times weekly) and reovirus (3 × 1010 TCID50, days 1-5, every 3 weeks). Clin Cancer Res; 16(22); 5564–72. ©2010 AACR." @default.
• W2103156714 created "2016-06-24" @default.
• W2103156714 creator A5006401570 @default.
• W2103156714 creator A5016566452 @default.
• W2103156714 creator A5033843118 @default.
• W2103156714 creator A5034748028 @default.
• W2103156714 creator A5062742458 @default.
• W2103156714 creator A5067211956 @default.
• W2103156714 creator A5069116024 @default.
• W2103156714 creator A5070554485 @default.
• W2103156714 creator A5072284989 @default.
• W2103156714 creator A5078521568 @default.
• W2103156714 creator A5081369976 @default.
• W2103156714 creator A5087028329 @default.
• W2103156714 creator A5090144505 @default.
• W2103156714 creator A5090413032 @default.
• W2103156714 creator A5090429618 @default.
• W2103156714 date "2010-11-14" @default.
• W2103156714 modified "2023-10-05" @default.
• W2103156714 title "REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer" @default.
• W2103156714 cites W1582164157 @default.
• W2103156714 cites W1854596437 @default.
• W2103156714 cites W1964170236 @default.
• W2103156714 cites W1964708778 @default.
• W2103156714 cites W1969063827 @default.
• W2103156714 cites W1979127187 @default.
• W2103156714 cites W1987741335 @default.
• W2103156714 cites W1992800374 @default.
• W2103156714 cites W2001334480 @default.
• W2103156714 cites W2026144469 @default.
• W2103156714 cites W2028577286 @default.
• W2103156714 cites W2054319806 @default.
• W2103156714 cites W2071260213 @default.
• W2103156714 cites W2094160798 @default.
• W2103156714 cites W2103803877 @default.
• W2103156714 cites W2104164469 @default.
• W2103156714 cites W2110410873 @default.
• W2103156714 cites W2113923002 @default.
• W2103156714 cites W2120067300 @default.
• W2103156714 cites W2125821230 @default.
• W2103156714 cites W2126015139 @default.
• W2103156714 cites W2127839329 @default.
• W2103156714 cites W2135686776 @default.
• W2103156714 cites W2139248078 @default.
• W2103156714 cites W2145340852 @default.
• W2103156714 cites W2166834600 @default.
• W2103156714 cites W2255506974 @default.
• W2103156714 doi "https://doi.org/10.1158/1078-0432.ccr-10-1233" @default.
• W2103156714 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3934355" @default.
• W2103156714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20926400" @default.
• W2103156714 hasPublicationYear "2010" @default.
• W2103156714 type Work @default.
• W2103156714 sameAs 2103156714 @default.
• W2103156714 citedByCount "122" @default.
• W2103156714 countsByYear W21031567142012 @default.
• W2103156714 countsByYear W21031567142013 @default.
• W2103156714 countsByYear W21031567142014 @default.
• W2103156714 countsByYear W21031567142015 @default.
• W2103156714 countsByYear W21031567142016 @default.
• W2103156714 countsByYear W21031567142017 @default.
• W2103156714 countsByYear W21031567142018 @default.
• W2103156714 countsByYear W21031567142019 @default.
• W2103156714 countsByYear W21031567142020 @default.
• W2103156714 countsByYear W21031567142021 @default.
• W2103156714 countsByYear W21031567142022 @default.
• W2103156714 countsByYear W21031567142023 @default.
• W2103156714 crossrefType "journal-article" @default.
• W2103156714 hasAuthorship W2103156714A5006401570 @default.
• W2103156714 hasAuthorship W2103156714A5016566452 @default.
• W2103156714 hasAuthorship W2103156714A5033843118 @default.
• W2103156714 hasAuthorship W2103156714A5034748028 @default.
• W2103156714 hasAuthorship W2103156714A5062742458 @default.
• W2103156714 hasAuthorship W2103156714A5067211956 @default.
• W2103156714 hasAuthorship W2103156714A5069116024 @default.
• W2103156714 hasAuthorship W2103156714A5070554485 @default.
• W2103156714 hasAuthorship W2103156714A5072284989 @default.
• W2103156714 hasAuthorship W2103156714A5078521568 @default.
• W2103156714 hasAuthorship W2103156714A5081369976 @default.
• W2103156714 hasAuthorship W2103156714A5087028329 @default.
• W2103156714 hasAuthorship W2103156714A5090144505 @default.
• W2103156714 hasAuthorship W2103156714A5090413032 @default.
• W2103156714 hasAuthorship W2103156714A5090429618 @default.
• W2103156714 hasBestOaLocation W21031567141 @default.
• W2103156714 hasConcept C121608353 @default.
• W2103156714 hasConcept C126322002 @default.
• W2103156714 hasConcept C143998085 @default.
• W2103156714 hasConcept C2776694085 @default.
• W2103156714 hasConcept C2777063308 @default.
• W2103156714 hasConcept C2778822529 @default.
• W2103156714 hasConcept C2781190966 @default.
• W2103156714 hasConcept C29730261 @default.
• W2103156714 hasConcept C31760486 @default.
• W2103156714 hasConcept C71924100 @default.
• W2103156714 hasConcept C82210918 @default.
• W2103156714 hasConcept C90924648 @default.
• W2103156714 hasConcept C98274493 @default.
• W2103156714 hasConceptScore W2103156714C121608353 @default.
• W2103156714 hasConceptScore W2103156714C126322002 @default.

• next